A pharmacist who dispenses a biological product shall communicate to the prescriber the name and manufacturer of the drug within five business days following the dispensing of the biological product. Communication shall occur via an entry in an interoperable electronic medical records system, an electronic prescribing technology, a pharmacy benefit management system or a pharmacy record that can be accessed electronically by the prescriber.